LV10054A - Pretvirusu antibakterials savienojums un lietosanas metode - Google Patents

Pretvirusu antibakterials savienojums un lietosanas metode

Info

Publication number
LV10054A
LV10054A LV920508A LV920508A LV10054A LV 10054 A LV10054 A LV 10054A LV 920508 A LV920508 A LV 920508A LV 920508 A LV920508 A LV 920508A LV 10054 A LV10054 A LV 10054A
Authority
LV
Latvia
Prior art keywords
administration
antibacterial compound
composition
disclosed
forms
Prior art date
Application number
LV920508A
Other languages
English (en)
Other versions
LV10054B (en
Inventor
Witold Kiczka
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of LV10054A publication Critical patent/LV10054A/lv
Publication of LV10054B publication Critical patent/LV10054B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LVP-92-508A 1988-05-26 1992-12-28 Antiviral or antibacterial compound and method of use LV10054B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17858888A 1988-05-26 1988-05-26
PCT/US1988/001785 WO1989011294A1 (en) 1988-05-26 1988-05-26 Antiviral or antibacterial compound and method of use
OA59731A OA09785A (en) 1988-05-26 1990-01-26 Antiviral or antibacterial compound and method of use

Publications (2)

Publication Number Publication Date
LV10054A true LV10054A (lv) 1994-05-10
LV10054B LV10054B (en) 1995-02-20

Family

ID=33162813

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-508A LV10054B (en) 1988-05-26 1992-12-28 Antiviral or antibacterial compound and method of use

Country Status (23)

Country Link
US (3) US5200182A (lv)
EP (1) EP0380484B1 (lv)
JP (1) JPH0649659B2 (lv)
AT (1) ATE93143T1 (lv)
AU (1) AU624331B2 (lv)
BG (1) BG60544B1 (lv)
CA (1) CA1335425C (lv)
CS (1) CS277030B6 (lv)
DK (1) DK173078B1 (lv)
ES (1) ES2011577A6 (lv)
FI (1) FI900412A0 (lv)
HK (1) HK42394A (lv)
HU (1) HU204710B (lv)
IL (1) IL90092A (lv)
LV (1) LV10054B (lv)
MA (1) MA21560A1 (lv)
MW (1) MW390A1 (lv)
OA (1) OA09785A (lv)
PH (1) PH26284A (lv)
RU (1) RU2092183C1 (lv)
WO (1) WO1989011294A1 (lv)
YU (1) YU109289A (lv)
ZA (1) ZA893382B (lv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017010856A1 (en) * 2015-07-14 2017-01-19 Rīgas Stradiņa Universitāte Composition for treatment of subclinical mastitis of cows

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2092183C1 (ru) * 1988-05-26 1997-10-10 Ника Хелт Продактс Лимитед (Лихтенштейн) Антивирусный или антибактериальный состав и способ его употребления
ATE136056T1 (de) * 1990-01-08 1996-04-15 Nika Health Products Ltd Verfahren zur herstellung von ribonuklease- dimeren
US5989880A (en) 1990-01-08 1999-11-23 Nika Health Products Ltd. Method of preparing lysozyme dimers
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
CH682541A5 (de) * 1992-06-23 1993-10-15 Urs Viktor Dr Wirth Biochemische Inaktivierung von RNA-Viren.
US6183742B1 (en) 1992-07-13 2001-02-06 Nika Health Products, Limited Applications of lysozyme dimer
DZ1964A1 (fr) * 1995-01-13 2002-10-15 Nika Health Products Ltd Nouvelle applications d'un dimère de lysozyme.
GB2304048A (en) * 1995-08-12 1997-03-12 John William Carson Medicament containing saliva extract
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
US7338936B2 (en) * 2000-11-28 2008-03-04 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
US6716813B2 (en) * 2000-11-28 2004-04-06 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
JP2002187853A (ja) * 2000-12-21 2002-07-05 Shinei Ferumentekku:Kk 動物の乳頭除菌剤および菌環境改善方法
DE10210285A1 (de) * 2002-03-08 2003-11-13 Medigene Ag Reversibles Toxin und seine Verwendung
WO2005115477A2 (en) 2004-04-13 2005-12-08 Quintessence Biosciences, Inc. Non-natural ribonuclease conjugates as cytotoxic agents
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
US7348301B2 (en) * 2006-02-16 2008-03-25 Buckman Laboratories International, Inc. Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems
EP2044097A4 (en) * 2006-06-23 2010-10-06 Quintessence Biosciences Inc MODIFIED RIBONUCLEASES
WO2008010991A2 (en) 2006-07-17 2008-01-24 Quintessence Biosciences, Inc. Methods and compositions for the treatment of cancer
US7846430B2 (en) * 2007-03-02 2010-12-07 Stefano Ferrari Composition and method for treating bovine papilloma virus in equine
US20100317677A1 (en) * 2007-09-11 2010-12-16 Hassel Bret A Methods of Treating a Microbial Infection by Modulating RNase-L Expression and/or Activity
JP2010540681A (ja) * 2007-10-08 2010-12-24 クインテッセンス バイオサイエンシズ，インコーポレーテッド リボヌクレアーゼに基づく治療のための組成物及び方法
JP2012504423A (ja) 2008-10-01 2012-02-23 クインテッセンス バイオサイエンシズ，インコーポレーテッド 治療用リボヌクレアーゼ
WO2010099182A1 (en) * 2009-02-25 2010-09-02 Board Of Regents Of The University Of Nebraska Activated creatinine and precursors as antibacterial agents, compositions and products containing such agents and uses thereof
NZ600269A (en) 2009-05-20 2014-02-28 Dec Int Nz Ltd Delivery device for treatment of mastitis
PL2457576T3 (pl) 2010-11-29 2021-04-06 Eurochit Danuta Kruszewska Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji
RU2548803C2 (ru) * 2011-11-28 2015-04-20 Общество с ограниченной ответственностью " Фарматренд" ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ ГЛАЗНЫХ ИНФЕКЦИЙ P. Aeruginosa, СОДЕРЖАЩАЯ РЕКОМБИНАНТНЫЙ ЛИЗОЦИМ
RU2509801C2 (ru) * 2012-03-22 2014-03-20 Борис Михайлович Куриненко СПОСОБ ИСПОЛЬЗОВАНИЯ РИБОНУКЛЕАЗЫ Bacillus intermedius
EP2674162A1 (en) 2012-05-29 2013-12-18 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
WO2013180585A1 (en) 2012-05-29 2013-12-05 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
RU2504397C1 (ru) * 2012-10-25 2014-01-20 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая фермент рибонуклеазу и глицирризиновую кислоту или ее соли: глицирризинат аммония, или дикалия, или тринатрия
WO2014152678A1 (en) 2013-03-15 2014-09-25 University Of Massachusetts Compositions and methods for delivering agents to the central nervous system
US9573980B2 (en) 2013-03-15 2017-02-21 Spogen Biotech Inc. Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots
WO2015125961A1 (ja) 2014-02-21 2015-08-27 国立大学法人東京海洋大学 ノロウィルス不活化剤及びその製造方法、ノロウィルス不活化方法、ノロウィルス不活化用リゾチーム類の製造方法、ノロウィルス感染の予防薬又は治療薬、並びにノロウィルス不活化用皮膚外用剤
KR20170038829A (ko) * 2014-07-31 2017-04-07 큐피가부시키가이샤 함수 유동상 조성물 및 그 제조 방법, 그리고 리소자임 가공품 및/또는 그 염 그리고 그 제조 방법
MX2017003465A (es) 2014-09-17 2017-06-19 Spogen Biotech Inc Proteinas de fusion, bacterias recombinantes y metodos de uso de las bacterias recombinantes.
RU2634264C1 (ru) * 2016-09-19 2017-10-24 Александр Ливиевич Ураков Крем-молочко для лечения опоясывающего лишая
KR102470362B1 (ko) 2016-12-28 2022-11-25 디아이씨 가부시끼가이샤 분산체 및 그것을 사용한 잉크젯용 잉크 조성물, 광변환층, 및 액정 표시 소자
US20220273733A1 (en) * 2019-07-26 2022-09-01 Evolve Biosystems, Inc. Nutritive compositions with bioactive proteins

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1268M (fr) * 1961-06-29 1962-04-24 Puiseux Médicament antimitotique et antiviral.
FR4020M (lv) * 1965-01-29 1966-03-21
DE1517751C3 (de) * 1965-07-08 1975-02-27 Eisai Co., Ltd., Tokio Verfahren zum Verhindern der Bildung von flockigen Lysozym- und/oder Lysozymsalzniederschlägen in wässrigen Lösungen, die Lysozym und/oder Lysozymsalze enthalten
DE1545644A1 (de) * 1965-12-06 1969-08-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen quaternaeren Scopolammoniumsalzen
GB1110504A (en) * 1966-03-18 1968-04-18 Prodotti Antibiotici Spa Pharmaceutical compositions
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
US4510144A (en) * 1981-08-26 1985-04-09 Newport Pharmaceuticals International Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
CA1263378A (en) * 1985-01-08 1989-11-28 Robert James Alaimo Imidazo¬4,5-f|quinolines useful as immunomodulating agents
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
RU2092183C1 (ru) * 1988-05-26 1997-10-10 Ника Хелт Продактс Лимитед (Лихтенштейн) Антивирусный или антибактериальный состав и способ его употребления

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017010856A1 (en) * 2015-07-14 2017-01-19 Rīgas Stradiņa Universitāte Composition for treatment of subclinical mastitis of cows

Also Published As

Publication number Publication date
FI900412A0 (fi) 1990-01-25
DK16890A (da) 1990-01-22
HK42394A (en) 1994-05-13
HUT54060A (en) 1991-01-28
BG60544B1 (en) 1995-08-28
JPH0649659B2 (ja) 1994-06-29
MW390A1 (en) 1990-11-14
YU109289A (en) 1991-08-31
AU1940888A (en) 1989-12-12
DK173078B1 (da) 1999-12-20
EP0380484B1 (en) 1993-08-18
ES2011577A6 (es) 1990-01-16
OA09785A (en) 1994-04-15
HU204710B (en) 1992-02-28
AU624331B2 (en) 1992-06-11
CS318089A3 (en) 1992-05-13
ATE93143T1 (de) 1993-09-15
EP0380484A1 (en) 1990-08-08
RU2092183C1 (ru) 1997-10-10
LV10054B (en) 1995-02-20
US5466449A (en) 1995-11-14
WO1989011294A1 (en) 1989-11-30
ZA893382B (en) 1991-01-30
CA1335425C (en) 1995-05-02
PH26284A (en) 1992-04-10
MA21560A1 (fr) 1989-12-31
DK16890D0 (da) 1990-01-22
JPH03504121A (ja) 1991-09-12
HU883981D0 (en) 1990-12-28
CS277030B6 (en) 1992-11-18
IL90092A (en) 1995-03-30
US6099835A (en) 2000-08-08
US5200182A (en) 1993-04-06

Similar Documents

Publication Publication Date Title
LV10054A (lv) Pretvirusu antibakterials savienojums un lietosanas metode
PT911033E (pt) Utilizacao do interferao de consenso para a reducao dos efeitos secundarios do tratamento com interferoes na hepatite viral
ES8700053A1 (es) Procedimiento de obtencion de una composicion para el trata-miento de infecciones virales
PT80157B (en) Methods of treating viral diseases with pyridazinamines anti-virally active pyridazinamines
WO1996028148A3 (en) Use of a r-nsaid in a protective composition for the treatment of colorectal cancer
DE69434963D1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
ITMI931522A1 (it) Composizione farmaceutiche per il trattamento dell'infezione da virus dell'epatite b (hbv)
FI935847A0 (fi) L-DOPA-esterkompositioner
EE9900428A (et) Köhavastased ravimkoostised
IT1187828B (it) Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
ZA929947B (en) Method of imparting antimicrobial activity to an opthalmic composition.
AU2840889A (en) Method of treating haematologic diseases and pharmaceutical compositions to be used therefor
JO1589B1 (en) Ketones (quaternary hydroimidazo (4.1) benzo-diazepine-2) anti-viral
ATE311897T1 (de) Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone
MY106984A (en) Antiviral or antibacterial composition and method of use.
GEP19971029B (en) Antiviral or antibacterial compound and method of use thereof
GR1001006B (el) Μεθοδος παρασκευης και χρησιμοποιησεως αντιιικων η αντιβακτηριακων συνθεσεων.
NO158186C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cis-2-(1h-imidazolylmethyl)-3-difluorbenzyloxy-2,3-dihydrofluorbenzo(b)thiofener.
IT1172264B (it) Enzima simile a pepsina da leucocito umano,procedimento per prepararlo,e composizione terapeutica che lo continene come ingrediente attivo
MX9307639A (es) Metodo para tratar infecciones virales con terapia conjuntiva con compuestos similares al aciclovir y un analogo de nucleosido 2'-viril substituido.